Manages symptom complex of tension (or muscle contraction) headache. ANDA 76560, held by Lgm Pharma. Acetaminophen; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 16, 2026, ANDA 76560 (Butalbital, Acetaminophen, Caffeine And Codeine Phosphate), held by Lgm Pharma, was first approved by FDA on Jun 10, 2004, with 7 approved supplements and 0 published complete response letters.
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are indicated for the management of the symptom complex of tension (or muscle contraction) headache when non-opioid analgesic and alternative treatments are inadequate.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 10, 2004 | Original application | Approved |
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate325MG;50MG;40MG;30MG · capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Rx |
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate300MG;50MG;40MG;30MG · capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Rx |
| Jun 18, 2026 | Supplement 13REMS | Approved | None posted |
| Oct 31, 2024 | Supplement 11REMS | Approved | None posted |
| Sep 18, 2018 | Supplement 8REMS | Approved | None posted |
| Mar 25, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jul 19, 2012 | Supplement 3Labeling | Approved | None posted |
| Jul 19, 2012 | Supplement 4Labeling | Approved | None posted |
| Oct 21, 2011 | Supplement 5Labeling | Approved | None posted |
| Jun 10, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters